Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasm Proteins | 7 | 2019 | 203 | 2.130 |
Why?
|
| Testicular Neoplasms | 7 | 2013 | 8 | 1.830 |
Why?
|
| Germ Cells | 6 | 2019 | 70 | 1.450 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 5 | 2010 | 5 | 1.410 |
Why?
|
| RNA, Messenger | 5 | 2019 | 1152 | 0.600 |
Why?
|
| Mice | 11 | 2019 | 5668 | 0.450 |
Why?
|
| Cytidine Deaminase | 2 | 2013 | 31 | 0.440 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 57 | 0.400 |
Why?
|
| Chromosomes, Mammalian | 2 | 2007 | 18 | 0.380 |
Why?
|
| Genetic Techniques | 1 | 2009 | 15 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 166 | 0.350 |
Why?
|
| Models, Animal | 1 | 2009 | 131 | 0.350 |
Why?
|
| X Chromosome | 1 | 2007 | 30 | 0.320 |
Why?
|
| Y Chromosome | 1 | 2007 | 49 | 0.310 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 283 | 0.310 |
Why?
|
| Animals | 11 | 2019 | 14307 | 0.300 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 522 | 0.300 |
Why?
|
| Embryonic Development | 1 | 2007 | 73 | 0.290 |
Why?
|
| Integrases | 2 | 2019 | 27 | 0.270 |
Why?
|
| Transcription Factors | 1 | 2010 | 653 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 528 | 0.250 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 608 | 0.230 |
Why?
|
| Seminoma | 2 | 2013 | 2 | 0.220 |
Why?
|
| Cell Line | 2 | 2019 | 1289 | 0.220 |
Why?
|
| Male | 10 | 2019 | 18870 | 0.210 |
Why?
|
| 3' Untranslated Regions | 3 | 2013 | 67 | 0.210 |
Why?
|
| Testis | 3 | 2008 | 185 | 0.210 |
Why?
|
| Mutation | 1 | 2005 | 1023 | 0.190 |
Why?
|
| Crosses, Genetic | 2 | 2009 | 48 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 145 | 0.160 |
Why?
|
| DNA, Complementary | 2 | 2008 | 175 | 0.150 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 117 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 605 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2013 | 386 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2009 | 562 | 0.130 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2013 | 1 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 2011 | 29 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2013 | 897 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 420 | 0.100 |
Why?
|
| Humans | 7 | 2019 | 34853 | 0.100 |
Why?
|
| Viscera | 1 | 2010 | 4 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 89 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2010 | 82 | 0.090 |
Why?
|
| Female | 3 | 2019 | 19873 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 184 | 0.090 |
Why?
|
| Protein Binding | 2 | 2013 | 913 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 133 | 0.090 |
Why?
|
| Gene Expression | 1 | 2011 | 639 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 78 | 0.080 |
Why?
|
| Pedigree | 1 | 2007 | 64 | 0.080 |
Why?
|
| Embryo Loss | 1 | 2007 | 5 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 152 | 0.070 |
Why?
|
| Sertoli Cells | 1 | 2007 | 43 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2007 | 121 | 0.070 |
Why?
|
| Antibodies | 1 | 2007 | 135 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 323 | 0.070 |
Why?
|
| Cell Movement | 1 | 2009 | 545 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1530 | 0.070 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 56 | 0.070 |
Why?
|
| Genotype | 1 | 2007 | 641 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 485 | 0.070 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 125 | 0.070 |
Why?
|
| Disease Progression | 1 | 2007 | 580 | 0.070 |
Why?
|
| Organ Size | 1 | 2005 | 148 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 159 | 0.060 |
Why?
|
| Alleles | 1 | 2005 | 284 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 642 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1149 | 0.060 |
Why?
|
| Cell Survival | 1 | 2007 | 818 | 0.060 |
Why?
|
| Base Sequence | 1 | 2005 | 932 | 0.060 |
Why?
|
| Body Weight | 1 | 2005 | 404 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2007 | 1442 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 781 | 0.050 |
Why?
|
| Pregnancy | 1 | 2007 | 1503 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 600 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1300 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 859 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2013 | 1961 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 21 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2013 | 29 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 83 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 707 | 0.020 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 4 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 12 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 18 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2010 | 39 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2010 | 46 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 211 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 628 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 968 | 0.020 |
Why?
|
| Proteins | 1 | 2010 | 352 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2010 | 1349 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 756 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 4012 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 6448 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 9642 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 11034 | 0.010 |
Why?
|